Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?

Authors	Andrew Graeme Affleck, Hywel Williams
Journal	Archives of dermatology (Arch Dermatol) Vol. 144 Issue 12 Pg. 1642-3 (Dec 2008) ISSN: 1538-3652 [Electronic] United States
PMID	19075151 (Publication Type: Case Reports, Journal Article)
Chemical References	Immunosuppressive Agents Isoxazoles Leflunomide
Topics	Evidence-Based Medicine Humans Immunosuppressive Agents (adverse effects, economics, therapeutic use) Isoxazoles (adverse effects, economics, therapeutic use) Leflunomide Male Psoriasis (drug therapy) Randomized Controlled Trials as Topic Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!